3G-BioInk

The joint project 3G-BioInk is developing and optimizing a platform technology that can be used as a screening tool for the research and development of innovative drugs.

Description

At the NMI, the focus is on research work on the production, fragmentation, sterilization and modification of electrospun bulk, hollow and core-sheath fibres for integration into bioinks for the production of innovative organ-like tissue models. Through a defined fiber morphology and fiber modification, the following limitations of previous tissue models are to be overcome:
(i) Initiation of directed cell growth (totographic guide rail) through an integration of biofunctionalized fibers (e.g. surface coating)
(ii) Site-resolved drug release through targeted placement of bulk or core-sheath fibers loaded with drugs/growth factors (e.g. in complex co-cultures)
(iii) Sufficient electrical stimulation by generating conductive structures using CNT-coated bulk fibers
(iv) Targeted nutrient supply even in larger or denser constructs through the integration of hollow fibers

Period:
01.07.2023 - 30.06.2026
FKZ:
16LW0360
Funding:
BMBF
Management:
VDI/VDE/IT

Projectlead

Dr. Hanna Hartmann

Head of Biomedicine & Material Sciences